Ayşe Özfer ÖZÇELİK, Funda Pınar ÇAKIROĞLU, Mustafa Volkan YILMAZ, Metin Saip SÜRÜCÜOĞLU, Gülperi HAKLI, AGED OVER OVER, Lale Sariye AKAN, Aslı UÇAR, Yahya ÖZDOĞAN, Esma ASİL

CARDIOVASCULAR RISK FACTORS ACCORDING TO FRAMINGHAM RISK SCORES IN INDIVIDUALS

Amaç: Kardiyovasküler hastalıklar (KVH) tüm dünyada mortalite ve morbititeyi arttırmada temel rol almaktadır. KVH riski risk faktörlerinin varlığıyla paralel artış gösterir. Bu çalışmada; 65 yaş ve üzerindeki bireylerin kardiyovasküler risk faktörlerinin belirlenmesi planlanmıştır. Gereç ve Yöntem: Araştırma Ankara'daki 10 sağlık ocağına gelen (Haziran-Temmuz 2009), 65 ve üzeri yaşta 127 gönüllü yaşlı birey ile yürütülmüştür (%30.7 erkek, %69.3 kadın, 70.0±4.7yıl). Kardiyovasküler risk Framingham risk skoru ile belirlenmiştir. Risk skorlamasında, LDL, HDL kolesterol, sistolik ve diastolik kan basıncı, diyabet varlığı ve sigara kullanımı temel alınmıştır. Bulgular: Katılımcıların ortalama total ve LDL kolesterol değerlerinin cinsiyete göre değiştiği bulunmuştur (p

65 YAŞ VE ÜSTÜ BİREYLERİN FRAMİNGHAM RİSK SKORUNA GÖRE KARDİYOVASKÜLER RİSK FAKTÖRLERİ

Aim: Cardiovascular disease (CVD) plays a major role in worldwide mortality and morbidity. The risk of CVD increases in parallel to the presence of its risk factors. This research was planned to determine the cardiovascular risk factors of individuals aged of 65 and over. Materials and methods: The research was carried out in 10 health care centers in Ankara (June-July, 2009) with 127 voluntary elderly subjects (30.7% male, 69.3% female) at the age of 65 and over (70.0±4.7 years). Cardiovascular risk was estimated with Framingham risk score. In the score age, LDL cholesterol (LDL-c), HDL cholesterol (HDL-c), systolic and diastolic blood pressure (SBP-DBP), diabetes and smoking habit were regarded as basis. Results: The average total and LDL-c values varied depending on sex (p

PDF

___

1. Pearson TA, Blair SN, Daniels SR, et al. AHA Guidelines for primary prevention of cardiovascular disease and stroke:2002 update. Circulation 2002;106:388-391.
2. Smith Jr SC, Allen J, Blair SN, et al. AHA/ACC Guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation 2006;113:2363 -2372.
3. Bitton A, Gaziano T. The Framingham Heart Study's impact on global risk assessment. Prog Cardiovasc Dis 2010;53:68-78.
4. Onat A. Halkımızda kalp damar riski yüksek bireylerin sayısı hakkında. Türk Kardiyol Dern Arş 2000;28:407-408.
5. Dawber TR, Kannel WB, Lyell L. An approach to longitudinal studies in a community: The Framingham Study. Ann N Y Acad Sci 1963;107:539- 556.
6. Dawber TR, Meadors GF, Moore FE. Epidemiological approaches to heart disease: The Framingham Study. Am J Public Health Nations Health 1951;41:279-281.
7. O'Donnell CJ, Elosua R. Cardiovascular risk factors. Insights from Framingham Heart Study. Rev Esp Cardiol 2008;61:299-310.
8. Güleç S. Kalp damar hastalıklarında global risk ve hedefler. Arch Turk Soc Cardiol 2009;37:1-10.
9. D'Agostino RB, Pencina MJ, Massaro JM, et al. Cardiovascular Disease Risk Assessment: Insights from Framingham. Glob Heart 2013;8:11-23.
10. Frohlich J, Al-Sarraf A. Cardiovascular risk and atherosclerosis prevention. Cardiovascular Pathology 2013;22:16-18.
11. Johns DJ, Lindroos AK, Jebb SA, et al. Dietary patterns, cardiometabolic risk factors, and the incidence of cardiovascular disease in severe obesity.Obesity 2015;23:1063-1070.
12. Kim JR, Oberman A, Fletcher GF, et al. Effect of exercise intensity and frequency on lipid levels in men with coronary heart disease: Training Level Comparison Trial. Am J Cardiol 2001;87:942-946.
13. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-1847.
14. World Health Organization- BMI Classification 2006. http://apps.who.int/bmi/index.jsp (Erişim Tarihi: 17/05/2014)
15. Unal B, Sözmen K, Uçku R, et al. High prevalence of cardiovascular risk factors in a Western urban Turkish population: a community-based study. Anadolu Kardiyol Derg 2013;13:9-17.
16. Wormser D, Kaptoge S, Di Angelantonio E, et al. Separate and combined associations of bodymass index and abdominal adiposity with cardiovascular disease: Collaborative analysis of 58 prospective studies. Lancet 2011;377:1085-1095.
17. Gondim OS, Camargo VT, Gutierrez FA, et al. Benefits of regular exercise on inflammatory and cardiovascular risk markers in normal weight, overweight and obese adults. PLOS One 2015;10: e0140596.
18. Vanhees L, Schepers D, Heidbuchel H, Defoor J, Fagard R. Exercise performance and training in patients with implantable cardioverterdefibrillators and coronary heart disease. Am J Cardiol 2001;87:712-715.
19. Church TS, Lavie CJ, Milani RV, Kirby GS. Improvements in blood rheology after cardiac rehabilitation and exercise training in patients with coronary heart Disease. Am Heart J 2002;143:349 -355.
20. Kirwan LD, Mertens DJ, Kavanagh, T, Thomas SG, et al. Exercise training in women with heart disease: Influence of hormone replacement therapy. Med Sci Sports Exerc 2003;35:185-192.
21. Thaulow E, Fredriksen PM. Exercise and training in adults with congenital heart disease. Int J Cardiol 2004;97:35-38.
22. Goldhammer E, Tanchilevitch A, Maor I, et al. Exercise training modulates cytokines activity in coronary heart disease patients. Int J Cardiol 2005;100:93-99.
23. Blumenthal JA, Sherwood A, Babyak MA, et al. Effects of exercise stress management training on markers of cardiovascular risk in patients with ischemic heart disease: A randomized controlled trial. JAMA 2005; 293:1626-1634.
24. Sanchis-Gomar F, Fiuza-Luces C, Lucia A. Exercise as the master polypill of the 21st century for the prevention of cardiovascular disease. Int J Cardiol 2015;181:360-361.
25. Özçelik AÖ, Sürücüoğlu MS, Yılmaz MV. Şarap ve Sağlık, "1. Ulusal Bağcılık ve Şarap Sempozyumu ve Sergisi Bildiri Kitabı". İzmir: Dinç Ofset; 2008:171 -178 .
26. Turhan NÖ. Kadın ve erkek sağlığını koruma stratejileri ve tarama programları. Turkiye Klinikleri J Med Sci 2008;28:255-261.
27. Uitewaal PJ, Goudswaard AN, Ubink-Veltmaat LJ, et al. Cardiovascular risk factors in Turkish immigrants with type 2 diabetes mellitus: Comparison with Dutch patients. Eur J Epidemiol 2004;19:923 -929.
28. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham Study. JAMA 1979;241:2035-2038 (abstract).
29. Li Q, Chen AH, Song XD, et al. Analysis of glucose levels and the risk for coronary heart disease in elderly patients in Guangzhou Haizhu district. Nan Fang Yi Ke Da Xue Xue Bao 2010;30:1275- 1278 (abstract).